Concourse Financial Group Securities’s Enveric Biosciences ENVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 2427 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 4059 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 4053 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 4091 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 4104 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 4043 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 4007 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 3967 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 3875 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 3840 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 3622 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 3673 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 3622 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 3749 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 3700 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 3597 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 3521 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 3444 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 3285 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 3189 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 3223 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 3166 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 2879 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 3207 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 3188 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 3071 |
|